Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibody Kinetics of Non-mandatory Marketed Vaccine
NCT06373510Not yet recruiting
- Start
- Jun 2024
- Primary completion
- Apr 2027
01
Overview
Open-label, single-arm trial in vaccine-preventable diseases (VPDs). Primary endpoint: Quantification of specific serum antibodies (IgM, IgG) at 3 years. Planned start Jun 2024; status: not yet recruiting.
02
Conditions
vaccine-preventable diseases (VPDs)
Beyond the preview
Go deeper on NCT06373510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06373510.